DYN Operating Cash Flow (Statement)
Dyne Therapeutics Inc · Operating Cash Flow (Statement)
DYN Operating Cash Flow (Statement)
Latest reported-$477.82Mperiod ending
DYN TTM Cash from Operations ($319.00M → -$477.82M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DYN operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -477,819,000 | |
| -442,236,000 | |
| -403,207,000 | |
| -375,710,000 | |
| -359,560,000 | |
| -319,725,000 | |
| -292,369,000 | |
| -243,040,000 | |
| -219,013,000 | |
| -219,787,000 | |
| -188,158,000 | |
| -182,344,000 | |
| -174,547,000 | |
| -149,814,000 | |
| -153,645,000 | |
| -152,521,000 | |
| -136,668,000 | |
| -151,909,000 | |
| -119,563,000 | |
| -111,531,000 | |
| -96,452,000 | |
| -57,613,000 | |
| -46,508,000 | |
| -30,486,000 | |
| -21,589,000 | |
| -16,700,000 | |
| -11,834,000 | |
| 76,180,000 | |
| 350,156,000 | |
| 433,578,000 | |
| 585,000,000 | |
| 528,000,000 | |
| 589,000,000 | |
| 634,000,000 | |
| 676,000,000 | |
| 441,000,000 | |
| 432,000,000 | |
| 340,000,000 | |
| 94,000,000 | |
| -36,000,000 | |
| -246,000,000 | |
| -283,000,000 | |
| -62,000,000 | |
| 319,000,000 | |
| 348,000,000 | |
| 348,000,000 | |
| 175,000,000 | |
| 169,000,000 | |
| 88,000,000 | |
| 13,000,000 | |
| 0 | |
| -107,000,000 | |
| -32,000,000 | |
| -123,000,000 | |
| -20,000,000 | |
| -197,000,000 | |
| -31,000,000 | |
| 503,083,761 | |
| 878,083,761 | |
| 956,083,761 | |
| 898,083,761 | |
| 428,000,000 | |
| 135,000,000 | |
| 226,000,000 | |
| 347,000,000 | |
| 338,000,000 | |
| 319,000,000 | |
| 372,000,000 | |
| 216,000,000 | |
| 443,000,000 |